Dendritic cells heterogeneity and its role in cancer immunity

Journal of Cancer Research and Therapeutics

Volumn 2, Issue 2, 2006, Pages 35-40

  Kah Wai, Lin ^a   Jacek, Tabarkiewicz ^b   Jacek, Rolinski ^b  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cancer; Dendritic cells; Immunity; Lymphoid; Myeloid

Indexed keywords

EID: 33745269548     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.25847     Document Type: Review

References (62)

1. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-87.
2. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002;82:97-130.
3. Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 1997;15:409-19.
4. Baggers J, Ratzinger G, Young JW. Dendritic cells as immunologic adjuvants for the treatment of cancer. J Clin Oncol 2000;18:3879-82.
5. Lutz MB, Schuler G. Immature, semi-immature and fully mature dendritic cells: which signals induce tolerance or immunity? Trend Immunol 2002;23:445-9.
6. Bachereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Ann Rev Immunol 2000;18:767-811.
7. Romo LF. In vivo maturation and migration of dendritic cells. Immunol 2001;102:255-62.
8. Lopez RM, Moser M. Dendritic cell subsets and the regulation of Th1/Th2 responses. Sem Immunol 2001;13:275-82.
9. Lanzavecchia A, Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001;13:291-8.
10. Ardavin C, Martinez del Hoyo G, Martin P, Anjuere F, Arias CF, Marin AR, et al. Origin and differentiation of dendritic cells. Trend Immunol 2001;22:691-700.
11. Vandenabeele S, Wu L. Dendritic cell origins: Puzzles and paradoxes. Immunol Cell Biol 1999;77:411-9.
12. Obermaier B, Dauer M, Herten J, Schad K, Endres S, Eigler A. Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online 2003;5:197-203.
13. Dauer M, Obermaier B, Herten J, Haerle C, Pohl K, Rothenfusser S, et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 2003;170:4069-76.
14. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic-cell pathways in response to GM-CSF and TNF-a. J Exp Med 1996;184:695-706.
15. Ito T, Inaba M, Inaba K, Toki J, Sogo S, Iguchi T, et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999;163:1409-19.
16. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997;94:12551-6.
17. Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 1993;362:761-3.
18. Wu L, Li CL, Shortman K. Thymic dendritic cell precursors: relationship to the T-lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med 1996;184:903-11.
19. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone-marrow cultures. Blood 2000;96:3029-39.
20. Saunders D, Lucas K, Ismaili J, Wu L, Maraskovsky E, Dunn A, et al. Dendritic-cell development in culture from thymic precursor cells in the absence of granulocyte-macrophage colony-stimulating factor. J Exp Med 1996;184:2185-96.
21. Galy A, Travis M, Cen D, Chen B. Human T, B natural killer and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995;3:459-73.
22. Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, Shortman K. Human thymus contains 2 distinct dendritic cell populations. Blood 2001;97:1733-41.
23. Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004;5:1227-34.
24. Summer KL, Hock BD, McKenzie JL, Hart DN. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol 2001;159:285-95.
25. Takahashi K, Asagoe K, Zaishum J, Yanai H, Yoshino T, Hayashi K, et al. Heterogeneity of dendritic cells in human superficial lymph node. In vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am J Pathol 1998;153:745-55.
26. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002;100:4512-20.
27. Ardavin C. Thymic dendritic cells. Rev Immunol Today 1997;18:350-61.
28. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31.
29. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood J Immunol 2000;165:6037-46.
30. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999;29:1743-51.
31. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000;164:2978-86.
32. Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR, et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003;102:2187-94.
33. Anjuere F, Martin P, Ferrero I, Fraga ML, del Hoya GM, Wright N, et al. Definition of Dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes and skin of the mouse. Blood 1999;93;590-8.
34. Vermare NB, Barthelemy C, Durand I, Bruand C, Dambuyant CD, Moulian N, et al. Human thymus contain IFN-a-producing CD11c-, myeloid CD11c+ and mature interdigitating dendritic cells. J Clin Invest 2001;107:835-44.
35. Wu L, Shortman K. Heterogeneity of thymic dendritic cells. Semin Immunol 2005;17:304-12.
36. th ed. Saunders, an imprint of Elsevier Science: USA; 2003. p. 391-410.
37. Greten TF, Jaffee EM. Cancer vaccines. J Clin Oncol 1999;17:1047-60.
38. Gabrilovich D. Mechanisms and functional significance of tumor-induced dendritic-cell defects. Nat Rev Immunol 2004;4:941-52.
39. Byrne S, Halliday GM. Dendritic cells: making progress with tumour regression? Immunol Cell Biol 2002;80:520-30.
40. Furihata M, Ohtsuki Y, Sonobe H, Araki K, Ogata T, Told T, et al. Prognostic significance of simultaneous infiltration of HLA-DR-positive dendritic cells and tumor infiltrating lymphocytes into human esophageal carcinoma. Tohoku J Exp Med 1993;169:187-95.
41. Ido E, Furihata M, Ohtsuki Y, Iwata J, Sonobe H. S-100 protein positive dendritic cells detected in hepatocellular carcinoma in relation to tumor progression and prognosis. Int J Oncol 1994;5:231-6.
42. Thurnher M, Radmayr C, Ramoner R, Ebner S, Bock G, Klocker H, et al. Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer 1996;68:1-7.
43. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 1998;4:585-93.
44. Mailliard RB, Dallal RM, Son YI, Lotze MT. Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen. Immunol Invest 2000;29:177-85.
45. Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006;12:207-13.
46. Chaudhry UI, Katz SC, Kingham TP, Pillarisetty VG, Raab JR, Shah AB, et al. In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells. FASEB J 2006 (Epub ahead of print)
47. Kao JY, Gong Y, Chen CM, Zheng QD, Chen JJ. Tumor-derived TGF-β reduces the efficacy of dendritic cell/tumor fusion vaccine. J Immunol 2003;170:3806-11.
48. Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunotherap 2004;53:534-50.
49. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, et al. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998;92:4778-91.
50. Corinti S, Albanesi C, Sala AI, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001;166;4312-8.
51. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000;114:295-302.
52. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood 1999;93:1634-42.
53. Wolfl M, Batten WY, Posovszky C, Bernhard H, Berthold F. Gangliosides inhibit the development from monocytes to dendritic cells. Clin Exp Immunol 2002;130:441-8.
54. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-6.
55. Wojas K, Tabarkiewicz J, Jankiewicz M, Rolinski J. Dendritic cells in peripheral blood of patients with breast and lung cancer - a pilot study Folia Histochem Cytobiol 2004;42:45-8.
56. Della Bella S, Gennaro M, Vaccari M, Ferraris C, Nicola S, Riva A, et al. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 2003;89:1463-72.
57. Hoffmann TK, Muller-Berghaus J, Ferris RL, Johnson JT, Storkus WJ, Whiteside TL. Alterations in the frequency of dendritic cells subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin Cancer Res 2002;8:1787-3.
58. Troy AJ, Davidson PJ, Atkinson CH, Hart DN. Phenotypic characterization of the dendritic cell infiltrate in prostate cancer. J Urol 1998;160:214-9.
59. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997;3:483-90.
60. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755-66.
61. Dallal RM, Lotze MT. The dendritic cell and human cancer vaccines. Curr Opin Immunol. 2000;12:583-8.
62. Santini SM, Belardelli F. Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines. Stem Cells 2003;21:495-505.